Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue

Cancer Research

Volumn 69, Issue 2, 2009, Pages 599-608

  Wieczorek, Georg ^a   Asemissen, Anne ^a   Model, Fabian ^d   Turbachova, Ivana ^a   Floess, Stefan ^a,e   Liebenberg, Volker ^a   Baron, Udo ^a   Stauch, Diana ^a   Kotsch, Katja ^a   Pratschke, Johann ^a   Hamann, Alf ^a   Loddenkemper, Christoph ^a   Stein, Harald ^a   Volk, Hans Dieter ^a   Hoffmüller, Ulrich ^a   Grützkau, Andreas ^b   Mustea, Alexander ^c   Huehn, Jochen ^a   Scheibenbogen, Carmen ^a   Olek, Sven ^a,c,f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c Tumorbank Ovarian Cancer   (Germany)

^d Occure GmbH   (Germany)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^f EPIONTIS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; BIOLOGICAL MARKER; INTERLEUKIN 2; MESSENGER RNA; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST CANCER; CANCER TRANSPLANTATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; FEMALE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG CANCER; LYMPHOCYTE DIFFERENTIATION; MALE; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; SOLID TUMOR; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; DNA METHYLATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; NEOPLASMS; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION IMMUNOLOGY;

EID: 58349116249     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2361     Document Type: Article

References (49)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-62.
2. + regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 2007;11:619-26.
3. + regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-9.
4. Huan J, Culbertson N, Spencer L, et al. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 2005;81:45-52.
5. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy, F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005;65:2457-64.
6. Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002;169:2756-61.
7. high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 2004;173:1444-53.
8. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-99.
9. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 2003;9:4404-8.
10. Beyer M, Schultze JL. Regulatory T cells in cancer. Blood 2006;108:804-11.
11. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9.
12. Bates GJ, Fox SB, Han C, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 2006;24:5373-80.
13. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004;9:665-74.
14. + regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. J Clin Oncol 2006;24:1169-77.
15. van der Vliet HJ, Koon HB, Yue SC, et al. Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer. Clin Cancer Res 2007;13:2100-8.
16. + regulatory T cells in cancer patients. Blood 2006;107:2409-14.
17. Bonnefoy-Bérard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991;51:669-73.
18. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP; CHIB 201 International Study Group. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997;350:1193-8.
19. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-1.
20. + regulatory T cells. Nat Immunol 2003;4:330-6.
21. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-61.
22. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:329-41.
23. Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 2005;102:5126-31.
24. Ziegler SF. FOXP3: not just for regulatory T cells anymore. Eur J Immunol 2007;37:21-3.
25. - T cells. J Clin Invest 2003;112:1437-43.
26. + regulatory T cells at the single-cell level. Eur J Immunol 2005;35:1681-91.
27. + regulatory T cells in human colorectal cancer. J Transl Med 2006;4:52.
28. Floess S, Freyer J, Siewert C, et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5:e38.
29. +) conventional T cells. Eur J Immunol 2007;37:2378-89.
30. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21.
31. Baron U, Türbachova I, Hellwag A, et al. DNA methylation analysis as a tool for cell typing. Epigenetics 2006;1:55-60.
32. Eckhardt F, Lewin J, Cortese R, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006;38:1378-85.
33. + regulatory T cells. J Exp Med 2004;199:303-13.
34. Asemissen AM, Scheibenbogen C, Letsch A, et al. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104). Clin Cancer Res 2005;11:290-7.
35. + regulatory T cells at the single-cell level. Eur J Immunol 2006;36:245.
36. Olek A, Oswald J, Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 1996;24:5064-6.
37. Rasmussen R. Quantification on the LightCycler. In: Meuer S, Wittwer C, Nakagawara K, editors. Rapid cycle real-time PCR, methods and applications. Heidelberg: Springer Press; 2001. p. 21-34.
38. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
39. - T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma. Hum Immunol 2006;67:1-12.
40. high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol 2006;177:7398-405.
41. Zuo T, Wang L, Morrison C, et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007;129:1275-86.
42. + T regulatory cells in murine pregnancy. J Reprod Immunol 2005;65:101-10.
43. + cells in vitro . Am J Transplant 2005;5:454-64.
44. Tkaczuk J, Yu CL, Baksh S, et al. Effect of anti-IL-2R α antibody on IL-2-induced Jak/STAT signaling. Am J Transplant 2002;2:31-40.
45. + regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE 2006;1:e129.
46. Ling KL, Pratap SE, Bates GJ, et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 2007;7:7.
47. Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008;54:414-23.
48. + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 2001;61:4766-72.
49. + regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 2006;10:2866-72.